Jeffrey B. Mirviss, EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP (BSX), sold 17,582 shares at $89.86 ($1.6M) on 2025-01-03, disclosed to the SEC on 2025-01-03.
Scheduled sale ($1.6M) by EVP&Pres, Periph Intervent under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.32 | 3,278 | $293K | 18.6% |
| 2 | $89.86 | 7,152 | $643K | 40.7% |
| 3 | $89.86 | 7,152 | $643K | 40.7% |
| Total | $89.76 avg | 17,582 | $1.6M | 100% |
| Filing → |
| BSX | SELL | 2025-02-13 | $2.7M | — | Filing → |
| BSX | SELL | 2024-05-30 | $9.6M | — | Filing → |
| BSX | SELL | 2024-03-19 | $1.9M | — | Filing → |